After a 4-week run-in period, patients were randomized to 12 weeks of treatment with digital GDH (Regulora®), or digital MR accessed via a mobile app on a smartphone or tablet. 
Regulora
After a 4-week run-in period, patients were randomized to 12 weeks of treatment with digital GDH (Regulora®), or digital MR accessed via a mobile app on a smartphone or tablet. 
mobile app on a smartphone or tablet